Australia markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.16-0.07 (-1.12%)
At close: 04:00PM EDT
5.86 -0.30 (-4.87%)
After hours: 04:08PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
516,697
512,345
512,117
430,898
321,161
-
Cost of revenue
172,038
184,152
181,037
128,192
87,642
-
Gross profit
344,659
328,193
331,080
302,706
233,519
-
Operating expenses
Research development
26,237
13,446
23,854
19,039
11,202
-
Selling general and administrative
335,819
303,879
332,134
254,253
193,078
-
Total operating expenses
378,156
326,167
365,736
281,655
211,719
-
Operating income or loss
-33,497
2,026
-34,656
21,051
21,800
-
Interest expense
11,882
40,676
12,021
1,112
9,751
-
Total other income/expenses net
-173,424
-82,461
-142,348
-10,451
3,865
-
Income before tax
-218,803
-121,111
-189,025
9,488
15,914
-
Income tax expense
-48,392
85
-44,374
-1,966
1,192
-
Income from continuing operations
-170,411
-121,196
-144,651
11,454
14,722
-
Net income
-127,138
-156,230
-158,704
19,375
16,411
-
Net income available to common shareholders
-127,138
-156,230
-158,704
19,375
16,411
-
Basic EPS
-2.92
-
-2.59
-0.15
0.44
0.12
Diluted EPS
-2.92
-
-2.59
-0.15
0.44
0.12
Basic average shares
62,353
-
61,389
59,549
37,697
55,625
Diluted average shares
62,353
-
61,389
59,549
37,697
55,625